Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
683 participants
INTERVENTIONAL
2011-12-31
2013-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Phase 3 Papulopustular Rosacea Study
NCT01494467
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
NCT01659853
Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea
NCT01355471
Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea
NCT01355458
A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Participants With Rosacea
NCT03287791
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CD5024
CD5024 1% Cream
CD5024
CD5024 1% Cream, once daily
CD5024 Vehicle
CD5024 Vehicle Cream
Azelaic acid 15% Gel
Topical Gel applied twice daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CD5024
CD5024 1% Cream, once daily
Azelaic acid 15% Gel
Topical Gel applied twice daily
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. The subject has at least 15 but not more than 70 inflammatory lesions (papules and pustules) on the face.
Exclusion Criteria
2. The subject has rosacea with more than two nodules on the face.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Galderma R&D
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Graeber, M.D.
Role: STUDY_DIRECTOR
Galderma R&D, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UAB Dermatology Clinical Research
Birmingham, Alabama, United States
Northwest AR Clinical Trials Center
Rogers, Arkansas, United States
Dermatology Research Associates
Los Angeles, California, United States
University Clinical Trials
San Diego, California, United States
Research Across America
Santa Ana, California, United States
Cherry Creek Research, Inc.
Denver, Colorado, United States
The Center for Clinical & Cosmetic Research
Aventura, Florida, United States
The Dermatology and Aesthetic Center
Boca Raton, Florida, United States
North Florida Dermatology Associates
Jacksonville, Florida, United States
FXM Research Miramar
Miramar, Florida, United States
MedaPhase, Inc.
Newnan, Georgia, United States
Laser & Skin Surgery Center of Indiana
Carmel, Indiana, United States
The Indiana Clinical Trials Center
Plainfield, Indiana, United States
The South Bend Clinic, LLP
South Bend, Indiana, United States
Derm Research, PLLC
Louisville, Kentucky, United States
Lawrence Green, MD, LLC
Rockville, Maryland, United States
Henry Ford Health Systems Department of Dermatology
Detroit, Michigan, United States
Grekin Skin Institute
Warren, Michigan, United States
Central Dermatology PC
St Louis, Missouri, United States
Skin Specialists, PC
Omaha, Nebraska, United States
Anderson & Collins Clinical Research,
Edison, New Jersey, United States
PMG Research of Charlotte
Charlotte, North Carolina, United States
Wake Research Associates
Raleigh, North Carolina, United States
Department of Dermatology - Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
Dermatology Research Center of Cincinnati
Cincinnati, Ohio, United States
Haber Dermatology Clinical Research Center
South Euclid, Ohio, United States
Central Sooner Research
Norman, Oklahoma, United States
Baker Allergy, Asthma and Dermatology Research Center
Lake Oswego, Oregon, United States
PMG Research of Charleston
Mt. Pleasant, South Carolina, United States
Palmetto Clinical Trial Services, LLC
Simpsonville, South Carolina, United States
TriCities Skin and Cancer
Johnson City, Tennessee, United States
Dermatology Associates of Kingsport, PC
Kingsport, Tennessee, United States
DermResearch, Inc.
Austin, Texas, United States
Modern Research Associates
Dallas, Texas, United States
Center for Clinical Studies
Houston, Texas, United States
Progressive Clinical Research
San Antonio, Texas, United States
Dermatology Research Center, Inc.
Salt Lake City, Utah, United States
The Education & Research Foundation, Inc.
Lynchburg, Virginia, United States
PLLC dba Dermatology Associates
Seattle, Washington, United States
The Polyclinic
Seattle, Washington, United States
Stratica Medical Inc
Edmonton, Alberta, Canada
Derm Research@888 Inc.
Vancouver, British Columbia, Canada
Dermadvances Research
Winnepeg, Manitoba, Canada
Nexus Clinical Research
St. John's, Newfoundland and Labrador, Canada
Eastern Canada Cutaneous Research Associates
Halifax, Nova Scotia, Canada
Skin Centre for Dermatology
Peterborough, Ontario, Canada
Toronto Research Centre, Inc.
Toronto, Ontario, Canada
Windsor Clinical Research, Inc.
Windsor, Ontario, Canada
Innovaderm Research. Inc
Montreal, Quebec, Canada
Siena Medical
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RD.06.SPR.18170
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.